UNH Stock Recent News
UNH LATEST HEADLINES
Despite trading at higher valuation multiples than its peers, the stock's fair value is between $529 and $720 per share, which is a 10% to 50% upside from current levels. Current economic uncertainty will propel investors to defensive, countercyclical stocks that consistently pay dividends, like UNH. Strong M&A activity in the field in 2023 is a growth catalyst.
UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to UnitedHealth (UNH). This makes it worthwhile to examine what the stock has in store.
The average brokerage recommendation (ABR) for UnitedHealth (UNH) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable.
UnitedHealth (UNH) expects the new Pathways for Aging program to serve around 100,000 people.
Recently, Zacks.com users have been paying close attention to UnitedHealth (UNH). This makes it worthwhile to examine what the stock has in store.
We believe that UnitedHealth stock (NYSE: UNH) is a better pick than HCA stock (NYSE: HCA), a healthcare facilities operator, given its better prospects.
Recently, Zacks.com users have been paying close attention to UnitedHealth (UNH). This makes it worthwhile to examine what the stock has in store.
UnitedHealth Group is trading below its 5-Yr average P/E ratio. The stock went down along its healthcare services peers, but UNH is not like any other health provider. The company's Optum businesses provide synergies and profitability its competitors can only dream of.
UnitedHealthGroup ( UNH , Financial) is a strong company that I believe has a very attractive risk-adjusted return profile. However, after a drawdown of nearly 10% in the stock price in the past six months, some investors must wonder if the bears are right about potential headwinds from the court ruling that the federal government can collect overpayments it made to the company due to UnitedHealth's misreporting on its Medicare Advantage plans.
Mariann Montagne, portfolio manager with Gradient Investments, joins ‘Power Lunch' to discuss consumer confidence, inflation and some of her favorite stocks, including UnitedHealth Group, Constellation and Walmart.